- Research works
- 34 ▲ 105% vs 2013–17
- Citations
- 318 9.2 per fractional work
- Top-10% rate
- 8.4% record average 16.5%
- Open access
- 60% world 28%
Not ranked overall: Amfissa General Hospital is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 22.4×. Every wedge is a field page.
Which keywords describe research at Amfissa General Hospital?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Risk Factors, Complications, Mortality, Rehabilitation, Cardiovascular Disease, Pathophysiology and Quality of Life.
- Innate Immunity
- Prevention
- HPV Vaccination
- Endothelial Dysfunction
- Cervical Cancer
- Surgical Treatment
- Skiing
- Surgery
- Chemotherapy
- Treatment
- Cancer
- Quality of Life
- Cardiovascular Disease
- Inflammation
- Risk Factors
- Epidemiology
- Complications
- Mortality
- Rehabilitation
- Pathophysiology
- Human Papillomavirus
- Cancer Incidence
- Obesity
- Diagnosis
- Snowboarding
- Antibiotic Resistance
- Chronic Pain
- Guidelines
- Patient Satisfaction
- Clinical Practice Guidelines
- Pentraxins
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 31 words, with their numbers
- Epidemiology7▲ 4.8×15 topics
- Risk Factors4▲ 10×5 topics
- Complications3▲ 19×8 topics
- Inflammation2▲ 3.1×7 topics
- Mortality2▲ 15×8 topics
- Cardiovascular Disease2▲ 6.1×6 topics
- Rehabilitation2▲ 18×4 topics
- Quality of Life2▲ 4.7×7 topics
- Pathophysiology2▲ 19×4 topics
- Cancer2▲ 3.2×5 topics
- Human Papillomavirus2▲ 35×2 topics
- Treatment2▲ 3.4×5 topics
- Cancer Incidence1▲ 29×2 topics
- Chemotherapy1▲ 5.9×5 topics
- Obesity1▲ 5.2×5 topics
- Surgery1▲ 13×5 topics
- Diagnosis1▲ 3.8×4 topics
- Skiing1▲ 175×1 topic
- Snowboarding1▲ 175×1 topic
- Surgical Treatment1▲ 19×3 topics
- Antibiotic Resistance1▲ 8.3×2 topics
- Cervical Cancer1▲ 37×1 topic
- Chronic Pain1▲ 16×3 topics
- Endothelial Dysfunction1▲ 12×3 topics
- Guidelines1▲ 7.4×4 topics
- HPV Vaccination1▲ 71×1 topic
- Patient Satisfaction1▲ 12×4 topics
- Prevention1▲ 8.1×2 topics
- Clinical Practice Guidelines1▲ 5.3×4 topics
- Innate Immunity1▲ 8.3×1 topic
- Pentraxins1▲ 257×1 topic
Which research topics does Amfissa General Hospital publish most on?
By volume in 2022–2025: Biomarkers in Disease Mechanisms, Infective Endocarditis Diagnosis and Management, Pediatric Urology and Nephrology Studies and Vibrio bacteria research studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Biomarkers in Disease Mechanisms Immunology 1 works
- 2 Infective Endocarditis Diagnosis and Management Epidemiology 0 works
- 3 Pediatric Urology and Nephrology Studies Pediatrics, Perinatology and Child Health 0 works
- 4 Vibrio bacteria research studies Endocrinology 0 works
- 5 Bacterial Infections and Vaccines Microbiology 0 works
- 6 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
- 7 Climate Change and Health Impacts Health, Toxicology and Mutagenesis 0 works
- 8 Escherichia coli research studies Endocrinology 0 works
- 9 Time Series Analysis and Forecasting Signal Processing 0 works
- 10 Data-Driven Disease Surveillance Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Amfissa General Hospital's research output changed?
Output in 2018–2022 was 105% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.